-      Bionaturis, a biopharmaceutical company listing on the Spanish Alternative Market, took part in the “Vaccine antivirals and Viral Immunology“ conference inside the series of “Veterinary Virology” on September 6th.

-       This conference took place at Universidad Complutense of Madrid from September 4th-7th with the slogan: “one world, one health, one virology”.

In its 9th edition, the International Congress of Veterinary Virology was headed by Dr. Jose Manuel Sánchez-Vizcaino, president of the European Society of Veterinary Virology (ESVV). The conference gathered different topics of veterinary virology such as vaccines, zoonosis, epidemiology, new virus, etc…

Bionaturis presented “the solution for a fast and affordable access to animal health” oral comunication, where Dr. Ana de las Heras (Bionaturis’ researcher) addressed the goals, methodology, and results of Bionaturis’ cutting-edge developments for an efficient, fast and safe prevention of animal diseases.

In order to achieve these objectives, Bionaturis takes advantage of its own production platform, FLYLIFE, which combines speed, efficiency, safety and financial feasibility to develop Second Generation vaccines to prevent, monitoring and eradicate viral diseases.

By means of FLYLIFE, Bionaturis’ research team is able to produce millions of vaccine batches short after  an alert is detected. This makes FLYLIFE a perfect tool to fight pandemic episodes, among others.

Víctor Infante, CEO of Bionaturis, emphasizes in how important is the participation of Bionaturis at this international conference: “It places FLYLIFE right inside of international veterinary virology so it can be known by the most prestigious scientists around the world.”